Biotech

Rayonier Advanced Materials Inc (NYSE:RYAM) shares popped 35.20% higher to $13.79 on Tuesday after the company printed its earnings report, with investors focusing on upbeat forecasts for the year. Rayonier Advanced Materials Inc (NYSE:RYAM) reported first quarter 2016 net income of $21 million or $0.49 diluted earnings per share. This is significantly...

Glaukos Corp (NYSE:GKOS) share prices advanced 24.66% to $24.77 on Wednesday after the company printed an impressive Q1 earnings report. Glaukos Corp (NYSE:GKOS) reported net sales of $23.1 million, 57% higher compared to the same quarter a year ago. Gross margins rose to 86%, allowing the company to rake in net income...

Depomed Inc (NASDAQ:DEPO) shares closed 15.09% higher to $17.85 on Monday, following reports of a stock outlook upgrade by Mizuho Securities. Depomed Inc (NASDAQ:DEPO) is a specialty pharmaceutical company focused on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER or tapentadol extended release tablets, which are used...

Argos Therapeutics Inc (NASDAQ:ARGS) shares were up 18.12% to $6.91 in Monday's New York session and an additional 2.17% in after-hours trading to $7.06. Argos Therapeutics Inc (NASDAQ:ARGS) shares hit a high of $7.64 on Monday before sliding lower, offering an opportunity to catch a short-term pullback. Prior to the early...

Cytori Therapeutics Inc (NASDAQ:CYTX) shares received a strong boost to $3.38 after the European Commission granted orphan drug status to the company's Cytori Cell Therapy® formulations. Cytori Therapeutics Inc (NASDAQ:CYTX) is a biotechnology company involved in the development of treatments and devices for a range of disorders using cells as a key...